Cargando…

Gleason Grade Group 4 prostate biopsy with no cancer seen on final pathology in the magnetic resonance imaging and Prostate Specific Membrane Antigen‐Positron Emission Tomography era

INTRODUCTION: The absence of prostate cancer on final surgical pathology after biopsy‐proven prostate cancer is a rare finding. CASE PRESENTATION: Case of pT0 prostate cancer following Gleason Grade Group 4 in 1 out of 12 cores from a transrectal ultrasound‐guided biopsy in a man who underwent both...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mookerji, Nikhile, Mittal, Rohan, Hui, Amaris, Pfanner, Tyler, Broomfield, Stacey, Dean, Luke, Adam, Benjamin, Fung, Christopher, Tamm, Alexander, Kinnaird, Adam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10622191/ https://www.ncbi.nlm.nih.gov/pubmed/37928279 http://dx.doi.org/10.1002/iju5.12614

Ejemplares similares

Micro-ultrasound Versus Magnetic Resonance Imaging in Prostate Cancer Active Surveillance
por: Albers, Patrick, et al.
Publicado: (2022)

Favorable intermediate risk prostate cancer with biopsy Gleason score of 6
por: Oh, Jong Jin, et al.
Publicado: (2021)

Predictive Factors of Gleason Score Upgrading in Localized and Locally Advanced Prostate Cancer Diagnosed by Prostate Biopsy
por: Moon, Seung Jin, et al.
Publicado: (2010)

Artificial intelligence assistance significantly improves Gleason grading of prostate biopsies by pathologists
por: Bulten, Wouter, et al.
Publicado: (2020)

Correlation of MRI-Lesion Targeted Biopsy vs. Systematic Biopsy Gleason Score with Final Pathological Gleason Score after Radical Prostatectomy
por: Wenzel, Mike, et al.
Publicado: (2021)

The values of neutrophil-lymphocyte ratio and/or prostate-specific antigen in discriminating real Gleason score ≥ 7 prostate cancer from group of biopsy-based Gleason score ≤ 6
por: Wang, Hanfeng, et al.
Publicado: (2017)

pT3 Predictive Factors in Patients with a Gleason Score of 6 in Prostate Biopsies
por: Kim, Sung Jin, et al.
Publicado: (2011)

Deep learning for automatic Gleason pattern classification for grade group determination of prostate biopsies
por: Lucas, Marit, et al.
Publicado: (2019)

Erratum: pT3 Predictive Factors in Patients with a Gleason Score of 6 in Prostate Biopsies
Publicado: (2011)

Gleason grading of prostate cancer in needle core biopsies: a comparison of general and urologic pathologists
por: Al-Maghrabi, Jaudah Ahmed, et al.
Publicado: (2013)

Correlation between body mass index (BMI) and the Gleason score of prostate biopsies in Chinese population
por: Zhou, Feng, et al.
Publicado: (2016)

Real-time diagnosis and Gleason grading of prostate core needle biopsies using nonlinear microscopy
por: Cahill, Lucas C., et al.
Publicado: (2021)

Prognostic Impact of Different Gleason Patterns on Biopsy Within Grade Group 4 Prostate Cancer
por: Mori, Keiichiro, et al.
Publicado: (2021)

Importance of prostate-specific antigen (PSA) as a predictive factor for concordance between the Gleason scores of prostate biopsies and RADICAL prostatectomy specimens
por: de Lima, Nelson Gianni, et al.
Publicado: (2013)

Significance of Nuclear Factor - Kappa Beta Activation on Prostate Needle Biopsy Samples in the Evaluation of Gleason Score 6 Prostatic Carcinoma Indolence
por: Zupancic, Marko, et al.
Publicado: (2020)

Prostate Cancer in Patients with Metabolic Syndrome Is Associated with Low Grade Gleason Score When Diagnosed on Biopsy
por: Jeon, Kyoung Pil, et al.
Publicado: (2012)

Importance and determinants of Gleason score undergrading on biopsy sample of prostate cancer in a population-based study
por: Rapiti, Elisabetta, et al.
Publicado: (2013)

Prostate cancer: Relationship between vascular diameter, shape and density and Gleason score in needle biopsy specimens
por: Tadayyon, Farhad, et al.
Publicado: (2013)

Development and Validation of a Deep Learning Algorithm for Gleason Grading of Prostate Cancer From Biopsy Specimens
por: Nagpal, Kunal, et al.
Publicado: (2020)

Association Between a 22-feature Genomic Classifier and Biopsy Gleason Upgrade During Active Surveillance for Prostate Cancer
por: Press, Benjamin H., et al.
Publicado: (2022)

Comparison of Gleason upgrading rates in transrectal ultrasound systematic random biopsies versus US-MRI fusion biopsies for prostate cancer
por: Kayano, Paulo Priante, et al.
Publicado: (2018)

The gut microbiota associated with high‐Gleason prostate cancer
por: Matsushita, Makoto, et al.
Publicado: (2021)

Gleason 6 prostate cancer: That which cannot be named
por: Burke, Harry B.
Publicado: (2022)

Quantitative (18)F-fluorocholine positron emission tomography for prostate cancer: correlation between kinetic parameters and Gleason scoring
por: Schaefferkoetter, Joshua D., et al.
Publicado: (2017)

Biochemical Recurrence in Gleason Score 7 Prostate Cancer in Korean Men: Significance of the Primary Gleason Grade
por: Ro, Yun Kwan, et al.
Publicado: (2012)

Interventions to improve the outcomes of frail people having surgery: A systematic review
por: McIsaac, Daniel I., et al.
Publicado: (2017)

Gleason score and tumor laterality in radical prostatectomy and transrectal ultrasound-guided biopsy of the prostate: a comparative study
por: Pereira, Renan A, et al.
Publicado: (2015)

Investigating association of perineural invasion on prostate biopsy with Gleason score upgrading at prostatectomy: A multi‐institutional analysis
por: Barsky, Andrew R., et al.
Publicado: (2020)

Personalised biopsy schedules based on risk of Gleason upgrading for patients with low‐risk prostate cancer on active surveillance
por: Tomer, Anirudh, et al.
Publicado: (2020)

The prevalence and risk factors of upgrading of Gleason grade group between transrectal ultrasound prostate biopsy and prostatectomy specimens
por: Promsen, Worapong, et al.
Publicado: (2023)

Re: Comparison of Gleason upgrading rates in transrectal ultrasound systematic random biopsies versus US-MRI fusion biopsies for prostate cancer
por: Bozkurt, Ibrahim Halil, et al.
Publicado: (2019)

Erratum to: Quantitative 18F-fluorocholine positron emission tomography for prostate cancer: correlation between kinetic parameters and Gleason scoring
por: Schaefferkoetter, Joshua D., et al.
Publicado: (2017)

Validation of the WHO 2016 new Gleason score of prostatic carcinoma
por: Rao, Vishal, et al.
Publicado: (2018)

Multimodal Radiomic Features for the Predicting Gleason Score of Prostate Cancer
por: Chaddad, Ahmad, et al.
Publicado: (2018)

Beyond the Gleason score: the prognostic significance of prostate cancer subtypes
por: Flood, Trevor A., et al.
Publicado: (2018)

Clinical significance of subtypes of Gleason pattern 4 prostate cancer
por: Hassan, Oudai, et al.
Publicado: (2018)

Expression of stromal elements of prostatic adenocarcinoma in different gleason scores
por: Osorio, Clarice Fraga Esteves Maciel, et al.
Publicado: (2019)

Self‐Identified African Americans and prostate cancer risk: West African genetic ancestry is associated with prostate cancer diagnosis and with higher Gleason sum on biopsy
por: Grizzle, William E., et al.
Publicado: (2019)

Clinical analysis of EV‐Fingerprint to predict grade group 3 and above prostate cancer and avoid prostate biopsy
por: Fairey, Adrian, et al.
Publicado: (2023)

Prediction of prostate cancer Gleason score upgrading from biopsy to radical prostatectomy using pre-biopsy multiparametric MRI PIRADS scoring system
por: Alqahtani, Saeed, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6prhhav3m4gjc8082bvt8u75eo